Ocugen Files 8-K on Security Holder Vote
Ticker: OCGN · Form: 8-K · Filed: Jun 28, 2024 · CIK: 1372299
| Field | Detail |
|---|---|
| Company | Ocugen, INC. (OCGN) |
| Form Type | 8-K |
| Filed Date | Jun 28, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: OCGN
TL;DR
OCGN filed an 8-K for a shareholder vote - details TBD.
AI Summary
Ocugen, Inc. filed an 8-K on June 28, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain details about the specific proposals voted on or the outcome of the vote.
Why It Matters
This filing indicates a corporate action involving shareholder voting, which could relate to significant company decisions or governance changes.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial or operational risks.
Key Players & Entities
- Ocugen, Inc. (company) — Registrant
- June 28, 2024 (date) — Date of Report
FAQ
What specific matters were submitted to a vote of Ocugen, Inc.'s security holders?
The filing states that matters were submitted to a vote of security holders, but does not specify what those matters were.
When did the event related to the security holder vote occur?
The earliest event reported in the filing occurred on June 28, 2024.
What is Ocugen, Inc.'s principal executive office address?
Ocugen, Inc.'s principal executive offices are located at 11 Great Valley Parkway, Malvern, Pennsylvania 19355.
What is Ocugen, Inc.'s IRS Employer Identification Number?
Ocugen, Inc.'s IRS Employer Identification Number is 04-3522315.
What is the Commission File Number for Ocugen, Inc.?
The Commission File Number for Ocugen, Inc. is 001-36751.
Filing Stats: 850 words · 3 min read · ~3 pages · Grade level 13 · Accepted 2024-06-28 16:11:16
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value per share OCGN The Nasdaq
Filing Documents
- tm2418567d1_8k.htm (8-K) — 39KB
- 0001104659-24-076278.txt ( ) — 207KB
- ocgn-20240628.xsd (EX-101.SCH) — 3KB
- ocgn-20240628_lab.xml (EX-101.LAB) — 33KB
- ocgn-20240628_pre.xml (EX-101.PRE) — 22KB
- tm2418567d1_8k_htm.xml (XML) — 3KB
07
Item 5.07 Submission of Matters to a Vote of Security Holders. On June 28, 2024, Ocugen, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting") virtually at 8:00 a.m. ET. At the Annual Meeting, a total of 107,738,208 shares of the Company's common stock, par value $0.01 (the "Common Stock"), and 107,845,946,208 shares of Series C Preferred Stock, par value $0.01 per share ("Series C Preferred Stock"), were represented virtually or by proxy. Each whole share of Series C Preferred Stock entitles the holder to one million votes per share. The following is a brief description of the final voting results for each of the proposals submitted to a vote of the stockholders at the Annual Meeting on June 28, 2024: (a) Proposal 1 - Election of Two Class I Directors. The stockholders elected each director nominee to the Board of Directors to serve as a director until the 2027 Annual Meeting of Stockholders and until their respective successor, if any, is elected or appointed, or upon their earlier death, resignation, retirement, disqualification, or removal, as follows: Name For Withheld Broker Non-Votes Shankar Musunuri, Ph. D., MBA 55,840,122 5,447,583 46,450,503 Junge Zhang, Ph. D. 54,459,369 6,828,336 46,450,503 (b) Proposal 2 - Ratification of Independent Registered Public Accountant . The Company withdrew the proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2024 fiscal year. (c) Proposal 3 - Approval, on an advisory basis, of the compensation of the Company's named executive officers. The stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers, as follows: Votes For Votes Against Abstentions Broker Non-Votes 48,751,037 10,722,166 1,814,502 46,450,503 (d) Proposal 4 – Approval of an amendment to the Company's charter to limit the liability of certain officers of